omidenepag isopropyl 0.02 MG/ML Ophthalmic Solution [Omlonti]
- RxCUI
- 2612704
- RxNorm name
- omidenepag isopropyl 0.02 MG/ML Ophthalmic Solution [Omlonti]
- Display name
- omidenepag isopropyl 0.02 MG/ML Ophthalmic Solution [Omlonti]
- Full name
- omidenepag isopropyl 0.02 MG/ML Ophthalmic Solution [Omlonti]
- Term type
- SBD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:55
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Omlonti | OMIDENEPAG ISOPROPYL | Ocuvex Therapeutics, Inc. | 4258e437-7e92-4b09-baf1-01cb158cfc05 | 2025-04-21 | Warnings, Adverse reactions | 2612704 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 4258e437-7e92-4b09-baf1-01cb158cfc05 | OMLONTI 0.002 % Ophthalmic Solution [PSN] · omidenepag isopropyl 0.02 MG/ML Ophthalmic Solution [Omlonti] [SBD] · OMLONTI 0.002 % Ophthalmic Solution [SY] · Omlonti 0.02 MG/ML Ophthalmic Solution [SY] | 4 | 3 | These highlights do not include all the information needed to use OMLONTI ® safely and effectively. See full prescribing information for OMLONTI ® . OMLONTI ® (omidenepag isopropyl ophthalmic solution) 0.002%, for topical ophthalmic use Initial U.S. Approval: 2022 | 20250421 |